Annual report pursuant to Section 13 and 15(d)

STOCKHOLDER???S EQUITY (Details Narrative)

v3.22.1
STOCKHOLDER’S EQUITY (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Apr. 02, 2021
Feb. 16, 2021
Aug. 17, 2020
Aug. 16, 2020
Feb. 07, 2020
Dec. 31, 2021
Jul. 31, 2021
May 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2016
Aug. 17, 2021
Apr. 02, 2020
Class of Stock [Line Items]                              
Loss on extinguishment                     $ (11,808,000)      
Common stock, par value           $ 0.0001     $ 0.0001   $ 0.0001 $ 0.0001      
Number of warrants issued to purchase common stock           3,409,200         3,409,200        
Payment for incentive fee           $ 100,000 $ 100,000                
Increase (decrease) in derivative liabilities                     $ (66,000)      
Debt instrument convertible conversion price           $ 0.50         $ 0.50        
Stock price volatility                     90.00%        
Risk-free interest rates                     0.66%        
Warrants exercised       $ 900,000                      
Warrants value                             $ 900,000
True Up Payment [Member]                              
Class of Stock [Line Items]                              
Number of warrants issued to purchase common stock     134,000                        
Warrant exercisable per share                           $ 1.25  
Warrants value                           $ 28,060  
2014 Stock Incentive Plan [Member]                              
Class of Stock [Line Items]                              
Warrant exercise price                   $ 0.50          
Common Stock [Member]                              
Class of Stock [Line Items]                              
Stock issued during period conversion of convertible securities                     1,374,000        
Other Investors [Member] | Common Stock [Member]                              
Class of Stock [Line Items]                              
Stock issued during period conversion of convertible securities                     150        
Maximum [Member]                              
Class of Stock [Line Items]                              
Risk-free interest rates                     0.20%        
Minimum [Member]                              
Class of Stock [Line Items]                              
Risk-free interest rates                     0.08%        
Chanticleer Holdings, Inc [Member] | 2014 Stock Incentive Plan [Member]                              
Class of Stock [Line Items]                              
Stock options granted                     400,010        
Deemed dividend                   $ 300,000          
Warrants exercised                   $ 1,200,000          
Chanticleer Holdings, Inc [Member] | Maximum [Member] | 2014 Stock Incentive Plan [Member]                              
Class of Stock [Line Items]                              
Stock price volatility                   95.00%          
Risk-free interest rates                   0.84%          
Weighted average term                   8 years          
Chanticleer Holdings, Inc [Member] | Minimum [Member] | 2014 Stock Incentive Plan [Member]                              
Class of Stock [Line Items]                              
Stock price volatility                   88.00%          
Risk-free interest rates                   1.70%          
Weighted average term                   6 years 6 months          
Sonnet Bio Therapeutics Inc [Member] | 2014 Stock Incentive Plan [Member]                              
Class of Stock [Line Items]                              
Warrants exercised $ 350,000                            
Redeemed warrants, shares 261,050                            
Redeemed warrants, value $ 100,000                            
Warrants remained shares 525,554                            
Warrant issued description Additionally, 3,275,200 warrants were issued, of which 2,925,200 warrants were issued with an exercise price ranging between $0.125 and $0.50 in connection with the issuance of the Company’s 10% convertible note agreement and 350,000 warrants with an exercise price of $1.25 were issued to the Company’s bridge financing investor                            
Convertible note agreement percentage 10.00%                            
Sonnet Bio Therapeutics Inc [Member] | Maximum [Member] | 2014 Stock Incentive Plan [Member]                              
Class of Stock [Line Items]                              
Warrant exercise price                             $ 0.50
Sonnet Bio Therapeutics Inc [Member] | Minimum [Member] | 2014 Stock Incentive Plan [Member]                              
Class of Stock [Line Items]                              
Warrant exercise price                             $ 0.125
True Up Payment [Member] | Original Investors [Member] | Common Stock [Member]                              
Class of Stock [Line Items]                              
Stock issued during period conversion of convertible securities               100,000     1,274,000        
2020 Bridge Financing [Member]                              
Class of Stock [Line Items]                              
Percentage of cash equal to dollar value                     1.25        
Fair value of the derivative liability                 $ 200,000     $ 200,000      
Redeemable Preferred Stock [Member]                              
Class of Stock [Line Items]                              
Redeemable preferred stock offering rights description                         the Company conducted a rights offering of units, each unit consisting of one share of 9% Redeemable Series 1 Preferred Stock (“Series 1 Preferred”) and one Series 1 Warrant (“Series 1 Warrant”) to purchase 10 shares of common stock.    
Warrant to purchase common stock                         10    
Preferred unit dividends                       37,518      
Redemption price                         $ 0.50    
Loss on extinguishment                       $ 200,000      
Convertible Preferred Stock: Series 2 [Member]                              
Class of Stock [Line Items]                              
Preferred stock, shares issued           100     787   100 787      
Convertible Preferred Stock: Series 2 [Member] | 2020 Bridge Financing [Member] | Securities Purchase Agreement [Member]                              
Class of Stock [Line Items]                              
Preferred stock, shares issued                 787 713   787      
Stock issued during period conversion of convertible securities                   1,426,849          
Convertible Preferred Stock: Series 2 [Member] | 2020 Bridge Financing [Member] | Securities Purchase Agreement [Member] | Chanticleer [Member]                              
Class of Stock [Line Items]                              
Sale of stock, number of shares         1,500                    
Gross proceeds preference stock         $ 1,500,000                    
Sale of stock, transaction costs         $ 100,000                    
Warrants term         5 years                    
Warrants to purchase common stock         350,000                    
Common stock, par value         $ 1.25                    
Preferred stock value         $ 1,000                    
Embedded derivative liability         500,000                    
Beneficial conversion feature         $ 700,000                    
Preferred Stock: Series 2 [Member]                              
Class of Stock [Line Items]                              
Stock issued during period conversion of convertible securities                     1,400        
Preferred Stock: Series 2 [Member] | 2020 Bridge Financing [Member]                              
Class of Stock [Line Items]                              
Preferred stock description                   the shareholders of Chanticleer common stock received shares of Amergent on a 1 for 1 basis (spin-off shares) and received 1 share of Sonnet common stock for 26 shares of Chanticleer common stock held at the time of the Merger          
Fair value of the derivative liability           $ 500,000         $ 500,000        
Increase (decrease) in derivative liabilities                 $ 300,000            
Debt instrument convertible conversion price           $ 1.00         $ 1.00        
Beneficial ownership percentage limitation           4.99%         4.99%        
Percentage of limitation prior to merger                     9.99%        
Preferred Stock: Series 2 [Member] | 2020 Bridge Financing [Member] | Maximum [Member]                              
Class of Stock [Line Items]                              
Common stock were issued value   $ 1,300,000                          
Preferred Stock: Series 2 [Member] | 2020 Bridge Financing [Member] | Minimum [Member]                              
Class of Stock [Line Items]                              
Common stock were issued value   $ 900,000                          
Series 2 Preferred Stock [Member]                              
Class of Stock [Line Items]                              
Cash payment to stock holders     $ 66,000                        
Number of warrants issued to purchase common stock     134,000                        
Common stock were issued value     $ 28,060                        
Series 2 Preferred Stock [Member] | Other Investors [Member]                              
Class of Stock [Line Items]                              
Stock issued during period conversion of convertible securities               50     100        
Series 2 Preferred Stock [Member] | True Up Payment [Member] | Original Investors [Member]                              
Class of Stock [Line Items]                              
Stock issued during period conversion of convertible securities                     637        
Series Two Preferred Stock [Member]                              
Class of Stock [Line Items]                              
Preferred stock value           $ 1,000         $ 1,000